FDA Inspection 1064726 — Aspire Fertility Institute Dallas
The FDA completed an inspection of Aspire Fertility Institute Dallas on August 22, 2018 in Addison, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 22, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Addison, TX (United States)